Skip to Content
Merck
All Photos(1)

Key Documents

192279

Sigma-Aldrich

1-Amino-1-cyclopentanemethanol

97%

Synonym(s):

Cycloleucinol

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
H2NC5H8CH2OH
CAS Number:
Molecular Weight:
115.17
EC Number:
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22

Assay

97%

bp

85-90 °C/10 mmHg (lit.)

mp

20 °C (lit.)

functional group

hydroxyl

SMILES string

NC1(CO)CCCC1

InChI

1S/C6H13NO/c7-6(5-8)3-1-2-4-6/h8H,1-5,7H2

InChI key

PDNZJLMPXLQDPL-UHFFFAOYSA-N

Application

1-Amino-1-cyclopentanemethanol was used in the synthesis of xanthine-derived heterocyclic fused systems. It was also used as building block in medicinal chemistry synthesis.

Pictograms

Exclamation mark

Signal Word

Warning

Hazard Statements

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

10 - Combustible liquids

WGK

WGK 3

Flash Point(F)

204.8 °F - closed cup

Flash Point(C)

96 °C - closed cup

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Paul V Fish et al.
Journal of medicinal chemistry, 50(10), 2341-2351 (2007-04-24)
1-isoquinolinylguanidines were previously disclosed as potent and selective inhibitors of urokinase-type plasminogen activator (uPA). Further investigation of this template has revealed that incorporation of a 7-sulfonamide group furnishes a new series of potent and highly selective uPA inhibitors. Potency and
Methods for the synthesis of xanthine-derived polycyclic fused systems.
Szymanska E, et al.
Heterocyclic Communications, 19(5), 297-310 (2013)
David C Pryde et al.
Journal of medicinal chemistry, 49(14), 4409-4424 (2006-07-11)
Female sexual arousal disorder (FSAD) is a highly prevalent sexual disorder affecting up to 40% of women. We describe herein our efforts to identify a selective neutral endopeptidase (NEP) inhibitor as a potential treatment for FSAD. The rationale for this

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service